About Analog Ventures
Analog Ventures, also referenced as J Ventures in Crunchbase records, is a US-based early-stage venture firm with a generalist software and consumer mandate. The firm’s public posture does not signal deep healthcare specialization, though they have likely participated in digital health and health-software rounds where the business resembles a fast-growing software company. For healthcare AI founders, Analog Ventures is best understood as a generalist seed and Series A co-investor: they bring software-investing rigor, network-driven sourcing, and a willingness to participate at $250K to $1.5M alongside a domain-specialist lead. Stage focus is seed and Series A. Founders who should approach: SaaS-flavored healthcare AI startups — RCM, prior auth, ambient documentation, scheduling, payer ops — where the metrics are SaaS-shaped and the regulatory profile is light to moderate. Founders who should not approach: founders needing specialist clinical or regulatory expertise, deep-tech biotech, and regulated medical devices. The realistic entry path is a warm introduction from a portfolio founder or co-investor; cold outbound via LinkedIn or their website is feasible but lower-yield given their generalist posture. Founders should expect SaaS-style diligence on growth, retention, and sales efficiency, with healthcare-specific questions deferred to specialist co-investors. Treat Analog as round-completion capital that brings software discipline rather than as a domain-driven anchor. Their Crunchbase page lists prior portfolio companies that map the network and provide referrer leads.
Founder reviews
Pitch / review this investor
Have you raised from Analog Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).